EMBLA MEDICAL Stock Price, News & Analysis
Company Description
EMBLA MEDICAL (OTC Link: OSSFF) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $2.1B.
OSSFF stock has declined 13.5% over the past year. Shares last traded at $4.15.
This page provides a comprehensive overview of OSSFF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
EMBLA MEDICAL (OSSFF) stock last traded at $4.15. Over the past 12 months, the stock has lost 13.5%. At a market capitalization of $2.1B, OSSFF is classified as a mid-cap stock with approximately 427.8M shares outstanding.
Latest News
EMBLA MEDICAL has 1 recent news article. View all OSSFF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in EMBLA MEDICAL (OSSFF) currently stands at 20 shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 99.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for EMBLA MEDICAL (OSSFF) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
OSSFF Company Profile & Sector Positioning
EMBLA MEDICAL (OSSFF) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing OSSFF often look at related companies in the same sector, including EMBLA MEDICAL (OSSUY), Vitrolife (VTRLY), Gn Store (GNNDY), Ambu A/S (AMBBY), and Elekta Ab (EKTAF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OSSFF's relative position within its industry.